The company in question is, Medivation, Inc. (NASDAQ:MDVN) currently with a stock price of 80.9 (0.04% today). The market cap for Medivation, Inc. is 13453.67, and is in the sector Healthcare, and Biotechnology industry. The target price for Medivation, Inc. is 77.15. Currently Medivation, Inc. is trading with a P/E of *TBA, and a forward P/E of 37.09. Average volume for Medivation, Inc. is 3968.06 and so far today it is 3079800.
Performance in the last year for Medivation, Inc. has been 59.98%. For EPS growth, Medivation, Inc. has seen a growth of -11.10%, and is looking to grow in the next year to 72.27%. More long term stats show that EPS growth has been 50.90% over the last five years and could be 37.68% for the next five years. Medivation, Inc. has seen sales growth quarter over quarter at 17.40%, with EPS growth quarter over quarter at *TBA. The 20-day simple moving average is 15.50%, with the 200-day simple moving average coming to 53.77%.
Since the IPO date for Medivation, Inc. on the 1/13/1997, Medivation, Inc. has seen performance year to date to be 67.36%. With Medivation, Inc. trading at 80.9, the dividend yield is *TBA, and the EPS is -1.17.
So could Medivation, Inc., be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 13.1 and the P/B is at 24.97. The P/cash is 41.12, with P/free cash flow at 44.21.
Medivation, Inc. ability to deal with debt shows that the current ratio is 4.3, and the quick ratio is 4.3. This is with long term debt/equity at 0, and total debt/equity at 0.
In terms of margins, Medivation, Inc. has a gross margin of *TBA, an operating margin of -26.30% and a profit margin of -17.20%.Payout ratio for Medivation, Inc. is *TBA. Return on assets come to -13.00% with return on investment coming to 27.10%.
Insider ownership for Medivation, Inc., is at 0.20% and institutional ownership comes to 91.30%. Outstanding shares are at 166.3. While shares float is 163.77. The float short is currently 1.98%, and short ratio is 0.82.